Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients

B. Shopsin, S. Gershon, M. Goldstein, E. Friedman, S. Wilk

Research output: Contribution to journalArticlepeer-review

157 Scopus citations

Abstract

Endogenously depressed patients who showed an antidepressant response to the tricyclic drug imipramine continued to show sustained well being after α MPT was added whereas depression returned when small doses of PCPA were added for brief periods. In one patient the antidepressant response to imipramine occurred after pre and continued treatment with α MPT. Urinary excretion levels of MHPG in one of the patients studied longitudinally did not correspond to the direction of clinical affective state but did reflect anticipated changes during α MPT treatment. Implications are that serotonergic mechanisms are likely involved in the antidepressant effects of imipramine in man.

Original languageEnglish
Pages (from-to)239-249
Number of pages11
JournalPsychopharmacology Communications
Volume1
Issue number2
StatePublished - 1975

Fingerprint

Dive into the research topics of 'Use of synthesis inhibitors in defining a role for biogenic amines during imipramine treatment in depressed patients'. Together they form a unique fingerprint.

Cite this